TrialNature medicine2021

Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial.

Yoshiaki Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.